© 2022 MJH Life Sciences and AJMC - Managed Care News, Research, and Expert Insights. All rights reserved.
© 2022 MJH Life Sciences™ and Clinical Care Targeted Communications, LLC. All rights reserved.
Key opinion leaders discuss the key differences and unmet needs in disease management for heart failure with preserved ejection fraction and heart failure with reduction ejection fraction.
November 24th 2020
An in-depth discussion on the clinical and economic burden of treatment for patients with heart failure, with special consideration to progressive disease.
An expert in the management of heart failure provides an overview of the progressive nature of the disease, with special consideration to biomarker monitorization.
December 1st 2020
A discussion on the link between LVEF, nT-proBNP, and cardiac remodeling in predicting disease progression.
A key opinion leader discusses how the medical understanding of heart failure has improved over the years and how it has helped management of disease.
December 8th 2020
Expert physicians consider the treatment goals for patients with heart failure.
An expert in the management of heart failure discusses the standard of care for patients with reduced ejection fraction.
December 15th 2020
Key opinion leaders provide an overview of the treatment gaps in the management of heart failure.
A discussion on utilization management strategies for optimizing the treatment for patients with heart failure.
December 22nd 2020
Key opinion leaders enumerate the challenges of treating patients with HFpEF.
Expert physicians consider how the treatment of patients differ when they have HFpEF versus HFrEF.